Synergy CHC Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Synergy CHC Corp. (SNYR) on February 27, 2026, reporting an event that occurred on the same date. The Company is incorporated in Nevada and operates in the health and wellness sector, specifically holding intellectual property for FOCUSfactor and Flat Tummy Co. products.
Key Financial Metrics
The filing does not provide current revenue, profit, cash flow, margin, debt, or liquidity figures. However, it references a prior transaction involving an aggregate license fee of $2.9 million, which the Company had previously recognized as revenue.
Material Changes
- Termination of Brand License Agreement: Gravity Pharma General Trading LLC ("Gravity") notified the Company of the termination, ab initio (from the beginning), of the Brand License Agreement dated March 31, 2025 (as amended on June 30, 2025).
- Scope of Agreement: The terminated agreement granted Gravity an exclusive license to sell and market FOCUSfactor and Flat Tummy Co. products in the United Arab Emirates and Turkey.
- Financial Impact: The $2.9 million license fee previously recorded as revenue is now subject to potential restatement or reversal due to the ab initio termination, though the filing does not explicitly state the immediate accounting adjustment.
Outlook, Risks, and Management Commentary
Management states that the Company continues to pursue the registration and marketing of the Licensed IP in the Territory (UAE and Turkey) despite the termination of the agreement with Gravity. The filing does not provide specific forward-looking guidance, updated risk factors, or details on contingencies beyond the termination event.
Investor Verification Checklist
- Verify the accounting treatment and potential reversal of the $2.9 million license fee previously recognized as revenue.
- Confirm the legal status of the ab initio termination and any ongoing disputes with Gravity Pharma General Trading LLC.
- Assess the Company's current strategy and resources for independently marketing products in the UAE and Turkey.
- Review subsequent filings for updates on the financial impact of this termination on the Company's most recent quarterly or annual results.